Antigenics Pulls Oncophage Application Following CHMP Negative Opinion
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
A month after it learned that Europe's Committee for Medicinal Products for Human Use would hand down a negative opinion on approval on Oncophage (vitespen), Antigenics withdrew its Marketing Application Authorization for the cancer vaccine on Nov. 20